Skip to main content
. Author manuscript; available in PMC: 2011 Feb 1.
Published in final edited form as: Behav Neurosci. 2010 Feb;124(1):44–54. doi: 10.1037/a0018283

Figure 2.

Figure 2

Intra-Acb scopolamine (10 μg/ 0.5 ul) significantly decreased sucrose pellet intake 3 h post infusion (A), but did not alter the latency to approach food compared to saline controls (B). Error bars depict one SEM. (*** p ≤ 0.001, significantly different from saline group)